PELVITAL USA, INC.
StreetZero Signal 60
About PELVITAL USA, INC.
Pelvital USA, Inc. is a women’s health medical device company based in Eagan, Minnesota, focused on restoring pelvic health with effective, convenient products backed by strong clinical evidence. Its first product, Flyte®, is an FDA-cleared in-home treatment for stress urinary incontinence and weakened pelvic floor muscles that delivers mechanotherapy. The company has closed multiple seed and seed-plus rounds totaling $5 million, with an additional prior private placement noted.
LATEST FUNDINGSeed
$520K
Announced 2026-10-05
TOTAL RAISED$9.5M
IN THE NEWS
- 🔗 About Pelvital – Flyte
- 🔗 Pelvital Announces $2.68 Million Seed Funding Round Led By Boomerang Ventures
- 🔗 Flyte by Pelvital Company Overview, Contact Details & Competitors | LeadIQ
- 🔗 Pelvital USA 2026 Company Profile: Valuation, Funding & Investors | PitchBook
- 🔗 Pelvital raises $2.3m to advance commercialisation of Flyte device
EMPLOYEES—
FOUNDED—
HQEagan, MN, United States
Industry
Other Health Care
Tags
Women's HealthMedical DeviceSeed
Key highlights
- Closed $2.68M seed round in 2023 led by Boomerang Ventures for Flyte development.
- Added $2.32M in seed-plus funding in 2024, oversubscribing the round at $5M total.
- Flyte is an FDA-cleared mechanotherapy device shown to treat stress urinary incontinence with 77% efficacy in trials.
- Headquartered in Eagan, MN with a focus on commercializing pelvic floor treatment technology.
- Backed by seven investors including Life Science Angels and Pier 70 Ventures.
Ask StreetZero about PELVITAL USA, INC.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account